Relapsing Multiple Sclerosis: Clinical Trials

1 trial for Relapsing Multiple Sclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Relapsing Multiple Sclerosis: new trials by email Literature Review of Relapsing Multiple Sclerosis trials Research Report on Relapsing Multiple Sclerosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CDP323 Biomarker Study
CDP323, Placebo - Relapsing Multiple Sclerosis
Phase 1 / Phase 2CompletedUCB Pharma712008-07-012011-09-12

Interventions

CDP323 (1)

Sponsors

UCB Pharma (1)

Countries

United Kingdom (1)

Results publications

PMID 23472197